NEWS
Novavax COVID vaccine could be months away said company rep
MELBOURNE: Regulatory approvals for the third pillar of Australia’s vaccine strategy may not be obtained… read more
CSL on path back to ‘normal’ claims JP Morgan researchers
MELBOURNE: JP Morgan has raised its price target for CSL from $261 to $266.20, predicting… read more
Gallin hits back over “opportunistic” McPherson’s takeover claims
MELBOURNE: Raphael Geminder’s investment vehicle Gallin has hit back at listed health and beauty company… read more
22 new senior healthcare executives sought for key roles
MELBOURNE: Twenty-two senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
